awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34687067-9463F16E-D3E4-4F6D-AB73-E0C38655B2C0
Q34687067-9463F16E-D3E4-4F6D-AB73-E0C38655B2C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34687067-9463F16E-D3E4-4F6D-AB73-E0C38655B2C0
A Phase I study of cyclin-dependent kinase inhibitor, AT7519, in patients with advanced cancer: NCIC Clinical Trials Group IND 177.
P2860
Q34687067-9463F16E-D3E4-4F6D-AB73-E0C38655B2C0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34687067-9463F16E-D3E4-4F6D-AB73-E0C38655B2C0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b5a096cbea5925b2a49b776956fac3d17e6e142d
P2860
Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines.